Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daiichi Sankyo
Pharma
ESMO: Datroway data edge out Trodelvy in first TROP2 face-off
While control arm crossover may explain the lack of an early survival showing for Trodelvy, it cannot explain another weak point in the drug's data.
Angus Liuu
Oct 19, 2025 2:30am
ESMO: Enhertu wields 2-fisted power in early breast cancer
Oct 18, 2025 10:30am
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
Oct 10, 2025 10:55am
AZ, Daiichi's Datroway scores overall survival win in TNBC
Oct 6, 2025 10:48am
Novo-KBP, Takeda, Enhertu—Fierce Pharma Asia
Oct 2, 2025 4:02pm
AZ, Daiichi's Enhertu notches another win in early breast cancer
Sep 29, 2025 12:00pm
